Global Point-of-Care Testing Market (POC): Global Industry Analysis and Forecast 2018-2026 by Product type, By End-User and By Region.

Global Point-of-Care Testing Market (POC): Global Industry Analysis and Forecast 2018-2026 by Product type, By End-User and By Region.

Market Scenario

Global Point-of-Care Testing Market (POC) was valued US$ 14Bn in 2017 and is anticipated to reach US$ 30Bn by 2026 at a CAGR of about 10.0% during a forecast.Global Point-of-Care Testing Market Global Point-of-Care (POC) Testing Market by product type, By Product Type, By End User and by region. Based on product type point of care market is segmented into Glucose Monitoring, Cardiac Markers, Infectious Diseases Testing, Cholesterol Testing, Coagulation Monitoring, Pregnancy And Fertility Testing, Haematology Testing, Blood Gas Testing & Others. By End-User are segmented in Clinics, Home, Laboratories, Assisted living healthcare facilities, Hospitals. Geographically into North America, Europe, Asia Pacific, Middle East & Africa, and Latin America. The driving factor for the point of care market is due to Rising in usage of home-based glucose monitoring systems, Coagulation Monitoring, Infectious Diseases Testing, in trending Pregnancy And Fertility Testing, developing technology and innovative launching scheme and best offers to eventually reduce public and national spending on health, These devices are being highly used for the rapid diagnosis of disease conditions for the early detection and management of the disease are the factor of growth in point of care market. High logistics costs and huge investment will be the restrains for point of care market. Global Point-of-Care (POC) Testing Market is segmented into by product, by Product Type, by End-user Type, and by geography. In terms Product Type, Infectious Diseases Testing will be in higher demand due to rising Point-of-care diagnostic are offering various schemes such as ease of use in remote areas, technological advancements, and lowered price points, tests are used in finger stick or capillary samples will be the key factor to boost the point of care market. In End, User segment Home Care will be fastest growing department due to Growing concern for early-stage disease detection and to avoid the occurrence of any chronic condition is expected to drive the remote monitoring and raise demand for rapid tests are a growth opportunity in the point-of-care testing market. Among region, Asia Pacific is expected to grow at the highest CAGR during the forecast period. The market growth in the region can be attributed to the emerging economies, increasing in disposal income, Large-scale rising population, changing lifestyle and early safety and precaution will lead the step in these regions to boost the point-of-care testing market in the Asia Pacific. Abbott Laboratories, Akers Biosciences, Inc., Alfa Scientific Designs, Inc, Amnisure International, Arlington Scientific, Inc, Becton Dickinson (BD), Biotron Diagnostics, Inc, Boson Biotech Co. Ltd, Chembio Diagnostic Systems, Inc, DRG International, Inc, Daktari Diagnostics, Diasys Diagnostic Systems Gmbh, Diazyme Laboratories, Inc., EKF Diagnostics Holdings plc, Eurolyser Diagnostica Gmbh, Getein Biomedical, Inc,. Hema Diagnostic Systems, LLC, Jant Pharmacal Corporation, Nova Biomedical, Corp., Princeton Biomeditech Corporation, Teco Diagnostics, Wama Diagnostica.

Scope of Global Point-of-Care (POC) Testing Market

Global Point-of-Care (POC) Testing Market by Product Type:

• Glucose Monitoring • Cardiac Markers • Infectious Diseases Testing • Cholesterol Testing • Coagulation Monitoring • Pregnancy and Fertility Testing • Hematology Testing • Blood Gas Testing • Others

Global Point-of-Care (POC) Testing Market by End-User Type

• Clinics • Home Care • Laboratories • Assisted living healthcare facilities • Hospitals

Global Point-of-Care (POC) Testing Market by Region

• North America • Europe • Asia Pacific • Middle East & Africa • Latin America

Key Player analyzed in the Report:

• Abbott • Beckman Coulter Inc. • Instrumentation Laboratory • Johnson & Johnson • Nova Biomedical • Qiagen • Roche Diagnostics Limited • Siemens AG • Abaxis, Inc. • Abbott Laboratories • Alfa Scientific Designs, Inc. • ARKRAY, Inc. • Ascencia Diabetes Care Holdings AG • Becton Dickinson and Company • bioMerieux SA • CHEMBIO DIAGNOSTICS, INC. • F. Hoffmann-La Roche AG • LamdaGen Corporation • Medtronic Public Limited Company • Nova Biomedical Global Wound Care Market

Table of Contents

Global Point-of-Care Testing Market

1. Preface 1.1. Report Scope and Market Segmentation 1.2. Research Highlights 1.3. Research Objectives 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: Global Point-of-Care (POC) Testing Size, by Market Value (US$ Mn) and Market Volume (Units) 4. Market Overview 4.1. Introduction 4.2. Market Indicator 4.2.1. Drivers 4.2.2. Restraints 4.2.3. Opportunities 4.2.4. Challenges 4.3. Porter’s Analysis 4.4. Value Chain Analysis 4.5. Market Risk Analysis 4.6. SWOT Analysis 4.7. Industry Trends and Emerging Technologies 4.8. Patent Registration 5. Supply Side and Demand Side Indicators 6. Global Point-of-Care (POC) Testing Market Analysis and Forecast 6.1. Global Point-of-Care (POC) Testing Market Size & Y-o-Y Growth Analysis 6.1.1. North America 6.1.2. Europe 6.1.3. Asia Pacific 6.1.4. Middle East & Africa 6.1.5. South America 7. Global Point-of-Care (POC) Testing Market Analysis and Forecast, by Product 7.1. Introduction and Definition 7.2. Key Findings 7.3. Global Point-of-Care (POC) Testing Market Value Share Analysis, by Product 7.4. Global Point-of-Care (POC) Testing Market Size (US$ Mn) Forecast, by Product 7.5. Global Point-of-Care (POC) Testing Market Analysis, by Product 7.6. Global Point-of-Care (POC) Testing Market Attractiveness Analysis, by Product 8. Global Point-of-Care (POC) Testing Market Analysis and Forecast, by Application 8.1. Introduction and Definition 8.2. Key Findings 8.3. Global Point-of-Care (POC) Testing Market Value Share Analysis, by Application 8.4. Global Point-of-Care (POC) Testing Market Size (US$ Mn) Forecast, by Application 8.5. Global Point-of-Care (POC) Testing Market Analysis, by Application 8.6. Global Point-of-Care (POC) Testing Market Attractiveness Analysis, by Application 9. Global Point-of-Care (POC) Testing Market Analysis, by Region 9.1. Global Point-of-Care (POC) Testing Market Value Share Analysis, by Region 9.2. Global Point-of-Care (POC) Testing Market Size (US$ Mn) Forecast, by Region 9.3. Global Point-of-Care (POC) Testing Market Attractiveness Analysis, by Region 10. North America Point-of-Care (POC) Testing Market Analysis 10.1. Key Findings 10.2. North America Point-of-Care (POC) Testing Market Overview 10.3. North America Point-of-Care (POC) Testing Market Value Share Analysis, by Product 10.4. North America Point-of-Care (POC) Testing Market Forecast, by Product 10.4.1. Glucose Monitoring 10.4.2. Cardiac Markers 10.4.3. Infectious Diseases Testing 10.4.4. Cholesterol Testing 10.4.5. Coagulation Monitoring 10.4.6. Pregnancy And Fertility Testing 10.4.7. Hematology Testing 10.4.8. Blood Gas Testing 10.4.9. Others 10.5. North America Point-of-Care (POC) Testing Market Value Share Analysis, by Application 10.6. North America Point-of-Care (POC) Testing Market Forecast, by Application 10.6.1. Clinics 10.6.2. Home Care 10.6.3. Laboratories 10.6.4. Assisted living healthcare facilities 10.6.5. Hospitals 10.7. North America Point-of-Care (POC) Testing Market Value Share Analysis, by Country 10.8. North America Point-of-Care (POC) Testing Market Forecast, by Country 10.8.1. U.S. 10.8.2. Canada 10.9. North America Point-of-Care (POC) Testing Market Analysis, by Country 10.10. U.S. Point-of-Care (POC) Testing Market Forecast, by Product 10.10.1. Glucose Monitoring 10.10.2. Cardiac Markers 10.10.3. Infectious Diseases Testing 10.10.4. Cholesterol Testing 10.10.5. Coagulation Monitoring 10.10.6. Pregnancy And Fertility Testing 10.10.7. Hematology Testing 10.10.8. Blood Gas Testing 10.10.9. Others 10.11. U.S. Point-of-Care (POC) Testing Market Forecast, by Application 10.11.1. Clinics 10.11.2. Home Care 10.11.3. Laboratories 10.11.4. Assisted living healthcare facilities 10.11.5. Hospitals 10.12. Canada Point-of-Care (POC) Testing Market Forecast, by Product 10.12.1. Glucose Monitoring 10.12.2. Cardiac Markers 10.12.3. Infectious Diseases Testing 10.12.4. Cholesterol Testing 10.12.5. Coagulation Monitoring 10.12.6. Pregnancy And Fertility Testing 10.12.7. Hematology Testing 10.12.8. Blood Gas Testing 10.12.9. Others 10.13. Canada Point-of-Care (POC) Testing Market Forecast, by Application 10.13.1. Clinics 10.13.2. Home Care 10.13.3. Laboratories 10.13.4. Assisted living healthcare facilities 10.13.5. Hospitals 10.14. North America Point-of-Care (POC) Testing Market Attractiveness Analysis 10.14.1. By Product 10.14.2. By Application 10.15. PEST Analysis 10.16. Key Trends 10.17. Key Development 11. Europe Point-of-Care (POC) Testing Market Analysis 11.1. Key Findings 11.2. Europe Point-of-Care (POC) Testing Market Overview 11.3. Europe Point-of-Care (POC) Testing Market Value Share Analysis, by Product 11.4. Europe Point-of-Care (POC) Testing Market Forecast, by Product 11.4.1. Glucose Monitoring 11.4.2. Cardiac Markers 11.4.3. Infectious Diseases Testing 11.4.4. Cholesterol Testing 11.4.5. Coagulation Monitoring 11.4.6. Pregnancy And Fertility Testing 11.4.7. Hematology Testing 11.4.8. Blood Gas Testing 11.4.9. Others 11.5. Europe Point-of-Care (POC) Testing Market Value Share Analysis, by Application 11.6. Europe Point-of-Care (POC) Testing Market Forecast, by Application 11.6.1. Clinics 11.6.2. Home Care 11.6.3. Laboratories 11.6.4. Assisted living healthcare facilities 11.6.5. Hospitals 11.6.6. Europe Point-of-Care (POC) Testing Market Value Share Analysis, by Country 11.7. Europe Point-of-Care (POC) Testing Market Forecast, by Country 11.7.1. Germany 11.7.2. U.K. 11.7.3. France 11.7.4. Italy 11.7.5. Spain 11.7.6. Rest of Europe 11.8. Europe Point-of-Care (POC) Testing Market Analysis, by Country 11.9. Germany Point-of-Care (POC) Testing Market Forecast, by Product 11.9.1. Glucose Monitoring 11.9.2. Cardiac Markers 11.9.3. Infectious Diseases Testing 11.9.4. Cholesterol Testing 11.9.5. Coagulation Monitoring 11.9.6. Pregnancy And Fertility Testing 11.9.7. Hematology Testing 11.9.8. Blood Gas Testing 11.9.9. Others 11.10. Germany Point-of-Care (POC) Testing Market Forecast, by Application 11.10.1. Clinics 11.10.2. Home Care 11.10.3. Laboratories 11.10.4. Assisted living healthcare facilities 11.10.5. Hospitals 11.11. U.K. Point-of-Care (POC) Testing Market Forecast, by Product 11.11.1. Glucose Monitoring 11.11.2. Cardiac Markers 11.11.3. Infectious Diseases Testing 11.11.4. Cholesterol Testing 11.11.5. Coagulation Monitoring 11.11.6. Pregnancy And Fertility Testing 11.11.7. Hematology Testing 11.11.8. Blood Gas Testing 11.11.9. Others 11.12. U.K. Point-of-Care (POC) Testing Market Forecast, by Application 11.12.1. Clinics 11.12.2. Home Care 11.12.3. Laboratories 11.12.4. Assisted living healthcare facilities 11.12.5. Hospitals 11.13. France Point-of-Care (POC) Testing Market Forecast, by Product 11.13.1. Glucose Monitoring 11.13.2. Cardiac Markers 11.13.3. Infectious Diseases Testing 11.13.4. Cholesterol Testing 11.13.5. Coagulation Monitoring 11.13.6. Pregnancy And Fertility Testing 11.13.7. Hematology Testing 11.13.8. Blood Gas Testing 11.13.9. Others 11.14. France Point-of-Care (POC) Testing Market Forecast, by Application 11.14.1. Clinics 11.14.2. Home Care 11.14.3. Laboratories 11.14.4. Assisted living healthcare facilities 11.14.5. Hospitals 11.15. Italy Point-of-Care (POC) Testing Market Forecast, by Product 11.15.1. Glucose Monitoring 11.15.2. Cardiac Markers 11.15.3. Infectious Diseases Testing 11.15.4. Cholesterol Testing 11.15.5. Coagulation Monitoring 11.15.6. Pregnancy And Fertility Testing 11.15.7. Hematology Testing 11.15.8. Blood Gas Testing 11.15.9. Others 11.16. Italy Point-of-Care (POC) Testing Market Forecast, by Application 11.16.1. Clinics 11.16.2. Home Care 11.16.3. Laboratories 11.16.4. Assisted living healthcare facilities 11.16.5. Hospitals 11.17. Spain Point-of-Care (POC) Testing Market Forecast, by Product 11.17.1. Glucose Monitoring 11.17.2. Cardiac Markers 11.17.3. Infectious Diseases Testing 11.17.4. Cholesterol Testing 11.17.5. Coagulation Monitoring 11.17.6. Pregnancy And Fertility Testing 11.17.7. Hematology Testing 11.17.8. Blood Gas Testing 11.17.9. Others 11.18. Spain Point-of-Care (POC) Testing Market Forecast, by Application 11.18.1. Clinics 11.18.2. Home Care 11.18.3. Laboratories 11.18.4. Assisted living healthcare facilities 11.18.5. Hospitals 11.19. Rest of Europe Point-of-Care (POC) Testing Market Forecast, by Product 11.19.1. Glucose Monitoring 11.19.2. Cardiac Markers 11.19.3. Infectious Diseases Testing 11.19.4. Cholesterol Testing 11.19.5. Coagulation Monitoring 11.19.6. Pregnancy And Fertility Testing 11.19.7. Hematology Testing 11.19.8. Blood Gas Testing 11.19.9. Others 11.20. Rest of Europe Point-of-Care (POC) Testing Market Forecast, by Application 11.20.1. Clinics 11.20.2. Home Care 11.20.3. Laboratories 11.20.4. Assisted living healthcare facilities 11.20.5. Hospitals 11.21. Europe Point-of-Care (POC) Testing Market Attractiveness Analysis 11.21.1. By Product 11.21.2. By Application 11.22. PEST Analysis 11.23. Key Trend 11.24. Key Development 12. Asia Pacific Point-of-Care (POC) Testing Market Analysis 12.1. Key Findings 12.2. Asia Pacific Point-of-Care (POC) Testing Market Overview 12.3. Asia Pacific Point-of-Care (POC) Testing Market Value Share Analysis, by Product 12.4. Asia Pacific Point-of-Care (POC) Testing Market Forecast, by Product 12.4.1. Glucose Monitoring 12.4.2. Cardiac Markers 12.4.3. Infectious Diseases Testing 12.4.4. Cholesterol Testing 12.4.5. Coagulation Monitoring 12.4.6. Pregnancy And Fertility Testing 12.4.7. Hematology Testing 12.4.8. Blood Gas Testing 12.4.9. Others 12.5. Asia Pacific Point-of-Care (POC) Testing Market Value Share Analysis, by Application 12.6. Asia Pacific Point-of-Care (POC) Testing Market Forecast, by Application 12.6.1. Clinics 12.6.2. Home Care 12.6.3. Laboratories 12.6.4. Assisted living healthcare facilities 12.6.5. Hospitals 12.7. Asia Pacific Point-of-Care (POC) Testing Market Value Share Analysis, by Country 12.8. Asia Pacific Point-of-Care (POC) Testing Market Forecast, by Country 12.8.1. China 12.8.2. India 12.8.3. Japan 12.8.4. ASEAN 12.8.5. Rest of Asia Pacific 12.9. Asia Pacific Point-of-Care (POC) Testing Market Analysis, by Country 12.10. China Point-of-Care (POC) Testing Market Forecast, by Product 12.10.1. Glucose Monitoring 12.10.2. Cardiac Markers 12.10.3. Infectious Diseases Testing 12.10.4. Cholesterol Testing 12.10.5. Coagulation Monitoring 12.10.6. Pregnancy And Fertility Testing 12.10.7. Hematology Testing 12.10.8. Blood Gas Testing 12.10.9. Others 12.11. China Point-of-Care (POC) Testing Market Forecast, by Application 12.11.1. Clinics 12.11.2. Home Care 12.11.3. Laboratories 12.11.4. Assisted living healthcare facilities 12.11.5. Hospitals 12.12. India Point-of-Care (POC) Testing Market Forecast, by Product 12.12.1. Glucose Monitoring 12.12.2. Cardiac Markers 12.12.3. Infectious Diseases Testing 12.12.4. Cholesterol Testing 12.12.5. Coagulation Monitoring 12.12.6. Pregnancy And Fertility Testing 12.12.7. Hematology Testing 12.12.8. Blood Gas Testing 12.12.9. Others 12.13. India Point-of-Care (POC) Testing Market Forecast, by Application 12.13.1. Clinics 12.13.2. Home Care 12.13.3. Laboratories 12.13.4. Assisted living healthcare facilities 12.13.5. Hospitals 12.14. Japan Point-of-Care (POC) Testing Market Forecast, by Product 12.14.1. Glucose Monitoring 12.14.2. Cardiac Markers 12.14.3. Infectious Diseases Testing 12.14.4. Cholesterol Testing 12.14.5. Coagulation Monitoring 12.14.6. Pregnancy And Fertility Testing 12.14.7. Hematology Testing 12.14.8. Blood Gas Testing 12.14.9. Others 12.15. Japan Point-of-Care (POC) Testing Market Forecast, by Application 12.15.1. Clinics 12.15.2. Home Care 12.15.3. Laboratories 12.15.4. Assisted living healthcare facilities 12.15.5. Hospitals 12.16. ASEAN Point-of-Care (POC) Testing Market Forecast, by Product 12.16.1. Glucose Monitoring 12.16.2. Cardiac Markers 12.16.3. Infectious Diseases Testing 12.16.4. Cholesterol Testing 12.16.5. Coagulation Monitoring 12.16.6. Pregnancy And Fertility Testing 12.16.7. Hematology Testing 12.16.8. Blood Gas Testing 12.16.9. Others 12.17. ASEAN Point-of-Care (POC) Testing Market Forecast, by Application 12.17.1. Clinics 12.17.2. Home Care 12.17.3. Laboratories 12.17.4. Assisted living healthcare facilities 12.17.5. Hospitals 12.18. Rest of Asia Pacific Point-of-Care (POC) Testing Market Forecast, by Product 12.18.1. Glucose Monitoring 12.18.2. Cardiac Markers 12.18.3. Infectious Diseases Testing 12.18.4. Cholesterol Testing 12.18.5. Coagulation Monitoring 12.18.6. Pregnancy And Fertility Testing 12.18.7. Hematology Testing 12.18.8. Blood Gas Testing 12.18.9. Others 12.19. Rest of Asia Pacific Point-of-Care (POC) Testing Market Forecast, by Application 12.19.1. Clinics 12.19.2. Home Care 12.19.3. Laboratories 12.19.4. Assisted living healthcare facilities 12.19.5. Hospitals 12.20. Asia Pacific Point-of-Care (POC) Testing Market Attractiveness Analysis 12.20.1. By Product 12.20.2. By Application 12.21. PEST Analysis 12.22. Key Trend 12.23. Key Development 13. Middle East & Africa Point-of-Care (POC) Testing Market Analysis 13.1. Key Findings 13.2. Middle East & Africa Point-of-Care (POC) Testing Market Overview 13.3. Middle East & Africa Point-of-Care (POC) Testing Market Value Share Analysis, by Product 13.4. Middle East & Africa Point-of-Care (POC) Testing Market Forecast, by Product 13.4.1. Glucose Monitoring 13.4.2. Cardiac Markers 13.4.3. Infectious Diseases Testing 13.4.4. Cholesterol Testing 13.4.5. Coagulation Monitoring 13.4.6. Pregnancy And Fertility Testing 13.4.7. Hematology Testing 13.4.8. Blood Gas Testing 13.4.9. Others 13.5. Middle East & Africa Point-of-Care (POC) Testing Market Value Share Analysis, by Application 13.6. Middle East & Africa Point-of-Care (POC) Testing Market Forecast, by Application 13.6.1. Clinics 13.6.2. Home Care 13.6.3. Laboratories 13.6.4. Assisted living healthcare facilities 13.6.5. Hospitals 13.7. Middle East & Africa Point-of-Care (POC) Testing Market Value Share Analysis, by Country 13.8. Middle East & Africa Point-of-Care (POC) Testing Market Forecast, by Country 13.8.1. GCC 13.8.2. South Africa 13.8.3. Rest of Middle East & Africa 13.9. Middle East & Africa Point-of-Care (POC) Testing Market Analysis, by Country 13.10. GCC Point-of-Care (POC) Testing Market Forecast, by Product 13.10.1. Glucose Monitoring 13.10.2. Cardiac Markers 13.10.3. Infectious Diseases Testing 13.10.4. Cholesterol Testing 13.10.5. Coagulation Monitoring 13.10.6. Pregnancy And Fertility Testing 13.10.7. Hematology Testing 13.10.8. Blood Gas Testing 13.10.9. Others 13.11. GCC Point-of-Care (POC) Testing Market Forecast, by Application 13.11.1. Clinics 13.11.2. Home Care 13.11.3. Laboratories 13.11.4. Assisted living healthcare facilities 13.11.5. Hospitals 13.12. South Africa Point-of-Care (POC) Testing Market Forecast, by Product 13.12.1. Glucose Monitoring 13.12.2. Cardiac Markers 13.12.3. Infectious Diseases Testing 13.12.4. Cholesterol Testing 13.12.5. Coagulation Monitoring 13.12.6. Pregnancy And Fertility Testing 13.12.7. Hematology Testing 13.12.8. Blood Gas Testing 13.12.9. Others 13.13. South Africa Point-of-Care (POC) Testing Market Forecast, by Application 13.13.1. Clinics 13.13.2. Home Care 13.13.3. Laboratories 13.13.4. Assisted living healthcare facilities 13.13.5. Hospitals 13.14. Rest of Middle East & Africa Point-of-Care (POC) Testing Market Forecast, by Product 13.14.1. Glucose Monitoring 13.14.2. Cardiac Markers 13.14.3. Infectious Diseases Testing 13.14.4. Cholesterol Testing 13.14.5. Coagulation Monitoring 13.14.6. Pregnancy And Fertility Testing 13.14.7. Hematology Testing 13.14.8. Blood Gas Testing 13.14.9. Others 13.15. Rest of Middle East & Africa Point-of-Care (POC) Testing Market Forecast, by Application 13.15.1. Clinics 13.15.2. Home Care 13.15.3. Laboratories 13.15.4. Assisted living healthcare facilities 13.15.5. Hospitals 13.16. Middle East & Africa Point-of-Care (POC) Testing Market Attractiveness Analysis 13.16.1. By Product 13.16.2. By Application 13.17. PEST Analysis 13.18. Key Trend 13.19. Key Development 14. South America Point-of-Care (POC) Testing Market Analysis 14.1. Key Findings 14.2. South America Point-of-Care (POC) Testing Market Overview 14.3. South America Point-of-Care (POC) Testing Market Value Share Analysis, by Product 14.4. South America Point-of-Care (POC) Testing Market Forecast, by Product 14.4.1. Glucose Monitoring 14.4.2. Cardiac Markers 14.4.3. Infectious Diseases Testing 14.4.4. Cholesterol Testing 14.4.5. Coagulation Monitoring 14.4.6. Pregnancy And Fertility Testing 14.4.7. Hematology Testing 14.4.8. Blood Gas Testing 14.4.9. Others 14.5. South America Point-of-Care (POC) Testing Market Value Share Analysis, by Application 14.6. South America Point-of-Care (POC) Testing Market Forecast, by Application 14.6.1. Clinics 14.6.2. Home Care 14.6.3. Laboratories 14.6.4. Assisted living healthcare facilities 14.6.5. Hospitals 14.7. South America Point-of-Care (POC) Testing Market Value Share Analysis, by Country 14.8. South America Point-of-Care (POC) Testing Market Forecast, by Country 14.8.1. Brazil 14.8.2. Mexico 14.8.3. Rest of South America 14.9. Brazil Point-of-Care (POC) Testing Market Forecast, by Product 14.9.1. Glucose Monitoring 14.9.2. Cardiac Markers 14.9.3. Infectious Diseases Testing 14.9.4. Cholesterol Testing 14.9.5. Coagulation Monitoring 14.9.6. Pregnancy And Fertility Testing 14.9.7. Hematology Testing 14.9.8. Blood Gas Testing 14.9.9. Others 14.10. Brazil Point-of-Care (POC) Testing Market Forecast, by Application 14.10.1. Clinics 14.10.2. Home Care 14.10.3. Laboratories 14.10.4. Assisted living healthcare facilities 14.10.5. Hospitals 14.11. Mexico Point-of-Care (POC) Testing Market Forecast, by Product 14.11.1. Glucose Monitoring 14.11.2. Cardiac Markers 14.11.3. Infectious Diseases Testing 14.11.4. Cholesterol Testing 14.11.5. Coagulation Monitoring 14.11.6. Pregnancy And Fertility Testing 14.11.7. Hematology Testing 14.11.8. Blood Gas Testing 14.11.9. Others 14.12. Mexico Point-of-Care (POC) Testing Market Forecast, by Application 14.12.1. Clinics 14.12.2. Home Care 14.12.3. Laboratories 14.12.4. Assisted living healthcare facilities 14.12.5. Hospitals 14.13. Rest of South America Point-of-Care (POC) Testing Market Forecast, by Product 14.13.1. Glucose Monitoring 14.13.2. Cardiac Markers 14.13.3. Infectious Diseases Testing 14.13.4. Cholesterol Testing 14.13.5. Coagulation Monitoring 14.13.6. Pregnancy And Fertility Testing 14.13.7. Hematology Testing 14.13.8. Blood Gas Testing 14.13.9. Others 14.14. Rest of South America Point-of-Care (POC) Testing Market Forecast, by Application 14.14.1. Clinics 14.14.2. Home Care 14.14.3. Laboratories 14.14.4. Assisted living healthcare facilities 14.14.5. Hospitals 14.15. South America Point-of-Care (POC) Testing Market Attractiveness Analysis 14.15.1. By Product 14.15.2. By Application 14.16. PEST Analysis 14.17. Key Trend 14.18. Key Development 15. Company Profiles 15.1. Market Share Analysis, by Company 15.2. Competition Matrix 15.2.1. Competitive Benchmarking of key players by price, presence, market share, Applications and R&D investment 15.2.2. New Product Launches and Product Enhancements 15.2.3. Market Consolidation 15.2.3.1. M&A by Regions, Investment and Applications 15.2.3.2. M&A Key Players, Forward Integration and Backward Integration 15.3. Company Profiles: Key Players 15.3.1. Abbott 15.3.1.1. Company Overview 15.3.1.2. Financial Overview 15.3.1.3. Product Portfolio 15.3.1.4. Business Strategy 15.3.1.5. Recent Developments 15.3.1.6. Manufacturing Footprint 15.3.2. Beckman Coulter Inc. 15.3.3. Instrumentation Laboratory 15.3.4. Johnson & Johnson 15.3.5. Nova Biomedical 15.3.6. Qiagen 15.3.7. Roche Diagnostics Limited 15.3.8. Siemens AG 15.3.9. Abaxis, Inc. 15.3.10. Abbott Laboratories 15.3.11. Alfa Scientific Designs, Inc. 15.3.12. ARKRAY, Inc. 15.3.13. Ascencia Diabetes Care Holdings AG 15.3.14. Becton Dickinson and Company 15.3.15. bioMerieux SA 15.3.16. CHEMBIO DIAGNOSTICS, INC. 15.3.17. F. Hoffmann-La Roche AG 15.3.18. LamdaGen Corporation 15.3.19. Medtronic Public Limited Company 15.3.20. Nova Biomedical 16. Primary Key Insights

Inquiry Before Buying

Request Sample

About This Report

Report ID15349
Category Healthcare
Publisher Name
No of Pages
Total Views
Published Date
Contact Us
Call Now